Circulating microrna expression profile and systemic right ventricular function in adults after atrial switch operation for complete transposition of the great arteries

BMC Cardiovascular Disorders

Volumn 13, Issue , 2013, Pages

  Lai, Clare T M ^a   Ng, Enders K O ^a   Chow, Pak cheong ^a   Kwong, Ava ^a   Cheung, Yiu fai ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Atrial switch; MicroRNA; Systemic ventricular function; Transposition of the great arteries

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; MICRORNA; MICRORNA 16; PROTEIN LET 7E; PROTEIN MIR 106A; PROTEIN MIR 18A; PROTEIN MIR 25; PROTEIN MIR 451; PROTEIN MIR 486 3P; PROTEIN MIR 486 5P; PROTEIN MIR 505; PROTEIN MIR 93; SPIRONOLACTONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GREAT VESSELS TRANSPOSITION; HEART RIGHT VENTRICLE FAILURE; HEART VENTRICLE CONTRACTILITY; HEART VENTRICLE CONTRACTION; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DOPPLER IMAGING; UPREGULATION; VALIDATION STUDY;

ADOLESCENT; ADULT; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; TRANSPOSITION OF GREAT VESSELS; VENTRICULAR FUNCTION, RIGHT; YOUNG ADULT;

EID: 84883781837     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-13-73     Document Type: Article

References (54)

1. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297. 10.1016/S0092-8674(04)00045-5, 14744438.
2. Reid G, Kirschner MB, van Zandwijk N. Circulating microRNAs: association with disease and potential use as biomarkers. Crit Rev Oncol Hematol 2011, 80:193-208. 10.1016/j.critrevonc.2010.11.004, 21145252.
3. Lee YS, Dutta A. MicroRNAs in cancer. Annu Rev Pathol 2009, 4:199-227. 10.1146/annurev.pathol.4.110807.092222, 2769253, 18817506.
4. Liu N, Olson EN. MicroRNA regulatory networks in cardiovascular development. Dev Cell 2010, 18:510-525. 10.1016/j.devcel.2010.03.010, 2922691, 20412767.
5. Wang J, Xu R, Lin F, Zhang S, Zhang G, Hu S, Zheng Z. MicroRNA: novel regulators involved in the remodeling and reverse remodeling of the heart. Cardiology 2009, 113:81-88. 10.1159/000172616, 19018142.
6. Divakaran V, Mann DL. The emerging role of microRNAs in cardiac remodeling and heart failure. Circ Res 2008, 103:1072-1083. 10.1161/CIRCRESAHA.108.183087, 18988904.
7. Bostjancic E, Zidar N, Glavac D. MicroRNA microarray expression profiling in human myocardial infarction. Dis Markers 2009, 27:255-268. 10.1155/2009/641082, 20075508.
8. Ikeda S, Kong SW, Lu J, Bisping E, Zhang H, Allen PD, Golub TR, Pieske B, Pu WT. Altered microRNA expression in human heart disease. Physiol Genomics 2007, 31:367-373. 10.1152/physiolgenomics.00144.2007, 17712037.
9. Matkovich SJ, Van Booven DJ, Youker KA, Torre-Amione G, Diwan A, Eschenbacher WH, Dorn LE, Watson MA, Margulies KB, Dorn GW. Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support. Circulation 2009, 119:1263-1271. 10.1161/CIRCULATIONAHA.108.813576, 2749457, 19237659.
10. Naga Prasad SV, Karnik S. MicroRNAs - regulators of signaling networks in dilated cardiomyopathy. J Cardiovasc Transl Res 2010, 3:225-234. 10.1007/s12265-010-9177-7, 20560044.
11. Carè A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P, Bang ML, Segnalini P, Gu Y, Dalton ND, Elia L, Latronico MV, Høydal M, Autore C, Russo MA, Dorn GW, Ellingsen O, Ruiz-Lozano P, Peterson KL, Croce CM, Peschle C, Condorelli G. MicroRNA-133 controls cardiac hypertrophy. Nat Med 2007, 13:613-618. 10.1038/nm1582, 17468766.
12. Cheng Y, Ji R, Yue J, Yang J, Liu X, Chen H, Dean DB, Zhang C. MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy?. Am J Pathol 2007, 170:1831-1840. 10.2353/ajpath.2007.061170, 1899438, 17525252.
13. Li P. MicroRNAs in cardiac apoptosis. J Cardiovasc Transl Res 2010, 3:219-224. 10.1007/s12265-010-9175-9, 20560043.
14. Martin MM, Lee EJ, Buckenberger JA, Schmittgen TD, Elton TS. MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts. J Biol Chem 2006, 281:18277-18284. 10.1074/jbc.M601496200, 16675453.
15. Romero DG, Plonczynski MW, Carvajal CA, Gomez-Sanchez EP, Gomez-Sanchez CE. Microribonucleic acid-21 increases aldosterone secretion and proliferation in H295R human adrenocortical cells. Endocrinology 2008, 149:2477-2483. 10.1210/en.2007-1686, 2329274, 18218696.
16. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, Zhang Y, Wang J, Jiang X, Xiang Y, Xu C, Zheng P, Zhang J, Li R, Zhang H, Shang X, Gong T, Ning G, Wang J, Zen K, Zhang J, Zhang CY. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008, 18:997-1006. 10.1038/cr.2008.282, 18766170.
17. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N, Benjamin H, Kushnir M, Cholakh H, Melamed N, Bentwich Z, Hod M, Goren Y, Chajut A. Serum microRNAs are promising novel biomarkers. PLoS One 2008, 3:e3148. 10.1371/journal.pone.0003148, 2519789, 18773077.
18. Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He J, Qin YW, Jing Q. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 2010, 31:659-666. 10.1093/eurheartj/ehq013, 20159880.
19. Tijsen AJ, Creemers EE, Moerland PD, de Windt LJ, van der Wal AC, Kok WE, Pinto YM. MiR423-5p as a circulating biomarker for heart failure. Circ Res 2010, 106:1035-1039. 10.1161/CIRCRESAHA.110.218297, 20185794.
20. Li S, Zhu J, Zhang W, Chen Y, Zhang K, Popescu LM, Ma X, Lau WB, Rong R, Yu X, Wang B, Li Y, Xiao C, Zhang M, Wang S, Yu L, Chen AF, Yang X, Cai J. Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection. Circulation 2011, 124:175-184. 10.1161/CIRCULATIONAHA.110.012237, 21690488.
21. Dos L, Teruel L, Ferreira IJ, Rodriguez-Larrea J, Miro L, Girona J, Albert DC, Gonçalves A, Murtra M, Casaldaliga J. Late outcome of Senning and Mustard procedures for correction of transposition of the great arteries. Heart 2005, 91:652-656. 10.1136/hrt.2003.029769, 1768896, 15831655.
22. Roos-Hesselink JW, Meijboom FJ, Spitaels SE, van Domburg R, van Rijen EH, Utens EM, McGhie J, Bos E, Bogers AJ, Simoons ML. Decline in ventricular function and clinical condition after Mustard repair for transposition of the great arteries (a prospective study of 22-29 years). Eur Heart J 2004, 25:1264-1270. 10.1016/j.ehj.2004.03.009, 15246646.
23. Derrick G, Deanfield JE. Decline in ventricular function and clinical condition after Mustard repair. Eur Heart J 2004, 25:1863-1864. 10.1016/j.ehj.2004.07.023, 15522463.
24. Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J, Poon TC, Ng SS, Sung JJ. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 2009, 58:1375-1381. 10.1136/gut.2008.167817, 19201770.
25. Vogel M, Schmidt MR, Kristiansen SB, Cheung M, White PA, Sorensen K, Redington AN. Validation of myocardial acceleration during isovolumic contraction as a novel noninvasive index of right ventricular contractility: comparison with ventricular pressure-volume relations in an animal model. Circulation 2002, 105:1693-1699. 10.1161/01.CIR.0000013773.67850.BA, 11940549.
26. Tutarel O, Dangwal S, Bretthauer J, Westhoff-Bleck M, Roentgen P, Anker SD, Bauersachs J, Thum T. Circulating miR-423_5p fails as a biomarker for systemic ventricular function in adults after atrial repair for transposition of the great arteries. Int J Cardiol 2011, Epub ahead of print.
27. Tan KS, Armugam A, Sepramaniam S, Lim KY, Setyowati KD, Wang CW, Jeyaseelan K. Expression profile of MicroRNAs in young stroke patients. PLoS One 2009, 4:e7689. 10.1371/journal.pone.0007689, 2765616, 19888324.
28. Caruso P, MacLean MR, Khanin R, McClure J, Soon E, Southgate M, MacDonald RA, Greig JA, Robertson KE, Masson R, Denby L, Dempsie Y, Long L, Morrell NW, Baker AH. Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline. Arterioscler Thromb Vasc Biol 2010, 30:716-723. 10.1161/ATVBAHA.109.202028, 20110569.
29. Dejean E, Renalier MH, Foisseau M, Agirre X, Joseph N, de Paiva GR, Al Saati T, Soulier J, Desjobert C, Lamant L, Prósper F, Felsher DW, Cavaillé J, Prats H, Delsol G, Giuriato S, Meggetto F. Hypoxia-microRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas. Leukemia 2011, 25:1882-1890. 10.1038/leu.2011.168, 21778999.
30. Doebele C, Bonauer A, Fischer A, Scholz A, Reiss Y, Urbich C, Hofmann WK, Zeiher AM, Dimmeler S. Members of the microRNA-17-92 cluster exhibit a cell-intrinsic antiangiogenic function in endothelial cells. Blood 2010, 115:4944-4950. 10.1182/blood-2010-01-264812, 20299512.
31. Kulshreshtha R, Davuluri RV, Calin GA, Ivan M. A microRNA component of the hypoxic response. Cell Death Differ 2008, 15:667-671. 10.1038/sj.cdd.4402310, 18219318.
32. Liu Q, Fu H, Sun F, Zhang H, Tie Y, Zhu J, Xing R, Sun Z, Zheng X. miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic Acids Res 2008, 36:5391-5404. 10.1093/nar/gkn522, 2532718, 18701644.
33. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A 2005, 102:13944-13949. 10.1073/pnas.0506654102, 1236577, 16166262.
34. Millane T, Bernard EJ, Jaeggi E, Howman-Giles RB, Uren RF, Cartmill TB, Hawker RE, Celermajer DS. Role of ischemia and infarction in late right ventricular dysfunction after atrial repair of transposition of the great arteries. J Am Coll Cardiol 2000, 35:1661-1668. 10.1016/S0735-1097(00)00585-4, 10807474.
35. Singh TP, Humes RA, Muzik O, Kottamasu S, Karpawich PP, Di Carli MF. Myocardial flow reserve in patients with a systemic right ventricle after atrial switch repair. J Am Coll Cardiol 2001, 37:2120-2125. 10.1016/S0735-1097(01)01283-9, 11419897.
36. Lai CT, Chow PC, Wong SJ, Chan KW, Cheung YF. Circulating annexin A5 levels after atrial switch for transposition of the great arteries: relationship with ventricular deformation and geometry. PLoS One 2012, 7:e52125. 10.1371/journal.pone.0052125, 3527428, 23284897.
37. Papadopoulos GL, Alexiou P, Maragkakis M, Reczko M, Hatzigeorgiou AG. DIANA-mirPath: Integrating human and mouse microRNAs in pathways. Bioinformatics 2009, 25:1991-1993. 10.1093/bioinformatics/btp299, 19435746.
38. Rose BA, Force T, Wang Y. Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol Rev 2010, 90:1507-1546. 10.1152/physrev.00054.2009, 20959622.
39. Naito AT, Shiojima I, Komuro I. Wnt signaling and aging-related heart disorders. Circ Res 2010, 107:1295-1303. 10.1161/CIRCRESAHA.110.223776, 21106946.
40. Leask A. TGFbeta, cardiac fibroblasts, and the fibrotic response. Cardiovasc Res 2007, 74:207-212. 10.1016/j.cardiores.2006.07.012, 16919613.
41. Shah AM, Mann DL. In search of new therapeutic targets and strategies for heart failure: recent advances in basic science. Lancet 2011, 378:704-712. 10.1016/S0140-6736(11)60894-5, 3486638, 21856484.
42. Song L, Lin C, Wu Z, Gong H, Zeng Y, Wu J, Li M, Li J. miR-18a impairs DNA damage response through downregulation of ataxia telangiectasia mutated (ATM) kinase. PLoS One 2011, 6:e25454. 10.1371/journal.pone.0025454, 3181320, 21980462.
43. Foster CR, Singh M, Subramanian V, Singh K. Ataxia telangiectasia mutated kinase plays a protective role in beta-adrenergic receptor-stimulated cardiac myocyte apoptosis and myocardial remodeling. Mol Cell Biochem 2011, 353:13-22. 10.1007/s11010-011-0769-6, 3106113, 21404020.
44. Small EM, O'Rourke JR, Moresi V, Sutherland LB, McAnally J, Gerard RD, Richardson JA, Olson EN. Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486. Proc Natl Acad Sci U S A 2010, 107:4218-4223. 10.1073/pnas.1000300107, 2840099, 20142475.
45. Crackower MA, Oudit GY, Kozieradzki I, Sarao R, Sun H, Sasaki T, Hirsch E, Suzuki A, Shioi T, Irie-Sasaki J, Sah R, Cheng HY, Rybin VO, Lembo G, Fratta L, Oliveira-dos-Santos AJ, Benovic JL, Kahn CR, Izumo S, Steinberg SF, Wymann MP, Backx PH, Penninger JM. Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways. Cell 2002, 110:737-749. 10.1016/S0092-8674(02)00969-8, 12297047.
46. Zu L, Shen Z, Wesley J, Cai ZP. PTEN inhibitors cause a negative inotropic and chronotropic effect in mice. Eur J Pharmacol 2011, 650:298-302. 10.1016/j.ejphar.2010.09.069, 2997895, 20951693.
47. Shiojima I, Sato K, Izumiya Y, Schiekofer S, Ito M, Liao R, Colucci WS, Walsh K. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 2005, 115:2108-2118. 10.1172/JCI24682, 1180541, 16075055.
48. van Almen GC, Verhesen W, van Leeuwen RE, van de Vrie M, Eurlings C, Schellings MW, Swinnen M, Cleutjens JP, van Zandvoort MA, Heymans S, Schroen B. MicroRNA-18 and microRNA-19 regulate CTGF and TSP-1 expression in age-related heart failure. Aging Cell 2011, 10:769-779. 10.1111/j.1474-9726.2011.00714.x, 3193380, 21501375.
49. Chow PC, Cheung EW, Chong CY, Lun KS, Yung TC, Wong KT, Chau AK, Cheung YF. Brain natriuretic peptide as a biomarker of systemic right ventricular function in patients with transposition of great arteries after atrial switch operation. Int J Cardiol 2008 2007, 127:192-197.
50. Vogt M, Kühn A, Wiese J, Eicken A, Hess J, Vogel M. Reduced contractile reserve of the systemic right ventricle under dobutamine stress is associated with increased brain natriuretic peptide levels in patients with complete transposition after atrial repair. Eur J Echocardiogr 2009, 10:691-694. 10.1093/ejechocard/jep047, 19401301.
51. Divakaran V, Adrogue J, Ishiyama M, Entman ML, Haudek S, Sivasubramanian N, Mann DL. Adaptive and maladptive effects of SMAD3 signaling in the adult heart after hemodynamic pressure overloading. Circ Heart Fail 2009, 2:633-642. 10.1161/CIRCHEARTFAILURE.108.823070, 3064555, 19919989.
52. Laterza OF, Lim L, Garrett-Engele PW, Vlasakova K, Muniappa N, Tanaka WK, Johnson JM, Sina JF, Fare TL, Sistare FD, Glaab WE. Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury. Clin Chem 2009, 55:1977-1983. 10.1373/clinchem.2009.131797, 19745058.
53. De Rosa S, Fichtlscherer S, Lehmann R, Assmus B, Dimmeler S, Zeiher AM. Transcoronary concentration gradients of circulating microRNAs. Circulation 2011, 124:1936-1944. 10.1161/CIRCULATIONAHA.111.037572, 21969012.
54. Gupta SK, Bang C, Thum T. Circulating microRNAs as biomarkers and potential paracrine mediators of cardiovascular disease. Circ Cardiovasc Genet 2010, 3:484-488. 10.1161/CIRCGENETICS.110.958363, 20959591.